105 related articles for article (PubMed ID: 31638205)
1. MicroRNA‑128‑b regulates epidermal growth factor receptor expression in non‑small cell lung cancer.
Li L; Wang D
Mol Med Rep; 2019 Dec; 20(6):4803-4810. PubMed ID: 31638205
[TBL] [Abstract][Full Text] [Related]
2. Long Noncoding RNA LINC00460 Promotes the Gefitinib Resistance of Nonsmall Cell Lung Cancer Through Epidermal Growth Factor Receptor by Sponging miR-769-5p.
Ma G; Zhu J; Liu F; Yang Y
DNA Cell Biol; 2019 Feb; 38(2):176-183. PubMed ID: 30601026
[TBL] [Abstract][Full Text] [Related]
3. miRNA-9 Inhibits Proliferation and Migration of Lung Squamous Cell Carcinoma Cells by Regulating NRSF/EGFR.
Wang K; Xu K; Leng X; Han Y; Fang Q
Technol Cancer Res Treat; 2020; 19():1533033820945807. PubMed ID: 32772818
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA‑145 inhibits migration and induces apoptosis in human non‑small cell lung cancer cells through regulation of the EGFR/PI3K/AKT signaling pathway.
Li B; Ding CM; Li YX; Peng JC; Geng N; Qin WW
Oncol Rep; 2018 Nov; 40(5):2944-2954. PubMed ID: 30226581
[TBL] [Abstract][Full Text] [Related]
5. EGFR regulation by microRNA in lung cancer: correlation with clinical response and survival to gefitinib and EGFR expression in cell lines.
Weiss GJ; Bemis LT; Nakajima E; Sugita M; Birks DK; Robinson WA; Varella-Garcia M; Bunn PA; Haney J; Helfrich BA; Kato H; Hirsch FR; Franklin WA
Ann Oncol; 2008 Jun; 19(6):1053-9. PubMed ID: 18304967
[TBL] [Abstract][Full Text] [Related]
6. miRNA-223 is an anticancer gene in human non-small cell lung cancer through the PI3K/AKT pathway by targeting EGFR.
Ma HP; Kong WX; Li XY; Li W; Zhang Y; Wu Y
Oncol Rep; 2019 Mar; 41(3):1549-1559. PubMed ID: 30747217
[TBL] [Abstract][Full Text] [Related]
7. EGFR may participate in immune evasion through regulation of B7‑H5 expression in non‑small cell lung carcinoma.
Dong Z; Zhang L; Xu W; Zhang G
Mol Med Rep; 2018 Oct; 18(4):3769-3779. PubMed ID: 30106102
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-27b reverses docetaxel resistance of non-small cell lung carcinoma cells via targeting epithelial growth factor receptor.
Chen S; Wang Q; Zhou XM; Zhu JP; Li T; Huang M
Mol Med Rep; 2016 Jul; 14(1):949-54. PubMed ID: 27221512
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-133b inhibits the growth of non-small-cell lung cancer by targeting the epidermal growth factor receptor.
Liu L; Shao X; Gao W; Zhang Z; Liu P; Wang R; Huang P; Yin Y; Shu Y
FEBS J; 2012 Oct; 279(20):3800-12. PubMed ID: 22883469
[TBL] [Abstract][Full Text] [Related]
10. Effect of microRNA-135a on Cell Proliferation, Migration, Invasion, Apoptosis and Tumor Angiogenesis Through the IGF-1/PI3K/Akt Signaling Pathway in Non-Small Cell Lung Cancer.
Zhou Y; Li S; Li J; Wang D; Li Q
Cell Physiol Biochem; 2017; 42(4):1431-1446. PubMed ID: 28715819
[TBL] [Abstract][Full Text] [Related]
11. miR‑497 suppresses malignant phenotype in non‑small cell lung cancer via targeting KDR.
Xia Y; Hu C; Lian L; Hui K; Wang L; Qiao Y; Liu L; Liang L; Jiang X
Oncol Rep; 2019 Jul; 42(1):443-452. PubMed ID: 31115562
[TBL] [Abstract][Full Text] [Related]
12. Antitumor effects of hsa‑miR661‑3p on non‑small cell lung cancer in vivo and in vitro.
Lu J; Gu X; Liu F; Rui Z; Liu M; Zhao L
Oncol Rep; 2019 May; 41(5):2987-2996. PubMed ID: 30896844
[TBL] [Abstract][Full Text] [Related]
13. Clinical Significance and Tumor-Suppressive Function of miR-516b in Nonsmall Cell Lung Cancer.
Zhu J; Zhang Y; Yang X; Jin L
Cancer Biother Radiopharm; 2017 May; 32(4):115-123. PubMed ID: 28514208
[TBL] [Abstract][Full Text] [Related]
14. Interferon regulatory factor 4 (IRF4) is overexpressed in human non‑small cell lung cancer (NSCLC) and activates the Notch signaling pathway.
Qian Y; Du Z; Xing Y; Zhou T; Chen T; Shi M
Mol Med Rep; 2017 Nov; 16(5):6034-6040. PubMed ID: 28849037
[TBL] [Abstract][Full Text] [Related]
15. Detection of Epidermal Growth Factor Receptor (EGFR) Gene Mutation in Formalin Fixed Paraffin Embedded Tissue by Polymerase Chain Reaction-Single Strand Conformational Polymorphism (PCR-SSCP) in Non-Small Cell Lung Cancer in the Northeastern Region of Thailand.
Saiyaros K; Kritpetcharat P; Pairojkul C; Sithithaworn J
Asian Pac J Cancer Prev; 2019 May; 20(5):1339-1343. PubMed ID: 31127887
[TBL] [Abstract][Full Text] [Related]
16. miR-134 inhibits non-small cell lung cancer growth by targeting the epidermal growth factor receptor.
Qin Q; Wei F; Zhang J; Wang X; Li B
J Cell Mol Med; 2016 Oct; 20(10):1974-83. PubMed ID: 27241841
[TBL] [Abstract][Full Text] [Related]
17. HOXA4-regulated miR-138 suppresses proliferation and gefitinib resistance in non-small cell lung cancer.
Tang X; Jiang J; Zhu J; He N; Tan J
Mol Genet Genomics; 2019 Feb; 294(1):85-93. PubMed ID: 30196354
[TBL] [Abstract][Full Text] [Related]
18. Unique microRNAs in lung adenocarcinoma groups according to major TKI sensitive EGFR mutation status.
Pak MG; Lee CH; Lee WJ; Shin DH; Roh MS
Diagn Pathol; 2015 Jul; 10():99. PubMed ID: 26170125
[TBL] [Abstract][Full Text] [Related]
19. Over-regulation of microRNA-133b inhibits cell proliferation of cisplatin-induced non-small cell lung cancer cells through PI3K/Akt and JAK2/STAT3 signaling pathway by targeting EGFR.
Li B; Ding CM; Li YX; Peng JC; Geng N; Qin WW
Oncol Rep; 2018 Mar; 39(3):1227-1234. PubMed ID: 29344640
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA‑4500 suppresses tumor progression in non‑small cell lung cancer by regulating STAT3.
Li ZY; Zhang ZZ; Bi H; Zhang QD; Zhang SJ; Zhou L; Zhu XQ; Zhou J
Mol Med Rep; 2019 Dec; 20(6):4973-4983. PubMed ID: 31638206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
